bioresearch-filters-purificationFeaturedArticles

  1. Emerging Technologies For Cell Therapy Manufacturing 4/7/2025

    This summary of the Cell & Gene Live, Emerging Technologies in Cell Therapy Manufacturing, explains why automation, robotics, AI, and digital tools offer a clear path to scalable, efficient, and patient-centric manufacturing.

  2. Homing In On Leaks: Rethinking AMI's Role In Water Conservation 5/7/2025
    New research indicates that the targeted deployment of advanced metering infrastructure (AMI) in leak-prone households, leveraging near real-time water use monitoring, could maximize their value.
  3. What's In Your DMF? 7/8/2024

    Are relevant Drug Master Files (DMFs) at your CDMO in good order or fully under consideration as part of your upcoming new-drug submissions to the FDA or other agencies? “I've lived with this on both sides, as an FDA official and at biopharma organizations,” says Ben Stevens, Director CMC Policy and Advocacy, GSK, and former  Branch Chief / Chemistry Reviewer at FDA. Here's what he advises.

  4. Neuromorphic Computing Breakthrough Could Be A Game-Changer 4/23/2025

    Neuromorphic computing uses principles from neuroscience to create devices that mimic neural systems, achieving efficient brain-like processing. It combines photonics and neuromorphic architectures for high efficiency and connectivity.

  5. Optimism For Biopharma In 2025 12/27/2024

    In this closing segment from the executive roundtable discussion, our panelists express their confidence in the industry's mission and maintain a positive outlook for the years ahead.

  6. Tyra Crystallizing The First Oral FGFR3 Therapy For Achondroplasia 9/30/2025

    Tyra Biosciences is using its SNÅP drug discovery platform to develop dabogratinib, the first oral FGFR3-selective therapy for achondroplasia, currently recruiting patients in Phase 2 trials.

  7. Tech Transfer 2025 – A High-Stakes Game Of Trust 8/4/2025

    Trust us. You'll want to read this editorial from Chief Editor Louis Garguilo, who was (gently) reminded he hadn't visited the subject of tech transfer in a while. He answers the questions both sponsors and CDMOs ask to gain the trust to make a tech transfer work for both sides.

  8. Fabled Route-Scouters Riding AI Applications 11/18/2024

    Route scouting professionals – self-effacing hunters of small-molecule simplicity, searching for efficient pathways to commercial success, fearless in pointing out risks, and at times, dead ends. Today they face mounting challenges. Can artificial intelligence (AI) bring more clairvoyance to these battered scientists? “Absolutely,” says Dr. Jürgen Swienty-Busch of Elsevier.

  9. 2025 Cell Therapy Outlook From BPI West 3/31/2025

    Bioprocess Online and Cell & Gene spoke with Takeda’s Amy Shaw at BPI West to discuss the industry and her key takeaways from the conference.

  10. Is Executive Leadership At Today's CDMOs Up To The Job? 11/11/2024

    A report from WittKieffer's Global Life Sciences provides a macro analysis of the executives that helm today’s CDMOs. Competent executive leadership should be a main driver of business-to-business confidence. So as a component of your CDMO due diligence, are you adequately assessing the senior executives at that organization? If so, do they inspire confidence that theirs is a well-governed and operated entity?